Proper Prescribing: Pharmacogenetics Testing Gains Traction but Requires a Delicate Balancing Act
Admera Health Director of Medical Affairs, Rubén Bonilla Guerrero featured in the latest edition of Clinical Omics magazine- Proper Prescribing: Pharmacogenetics Testing Gains Traction but Requires a Delicate Balancing Act By Frieda Wiley, PharmD on Clinicalomics.com. Since the completion of the Human Genome Project in 2003, the pharmacogenomics industry [...]
Inc. Magazine Unveils Its Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000
Admera Health Ranks No. 511 on the 2019 Inc. 5000 With Three-Year Revenue Growth of 855 Percent NEW YORK, Aug. 20, 2019 (GLOBE NEWSWIRE)-- Inc. magazine today revealed that Admera Health is No. 511 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The [...]
Massive Bio to Present SYNERGY-AI Trial-in-Progress Poster Presentation at Upcoming AACR 2019 using its AI Clinical Trial Matching Technology, and Announces Strategic Partnership in Precision Oncology with US-Based Admera Health
NEW YORK, April 02, 2019 (GLOBE NEWSWIRE) -- Massive Bio, Inc., a leader in providing simplified and affordable access to clinical trials and precision oncology to cancer patients treated at community-based oncology practices, announced today that its Trials-in-Progress poster titled “SYNERGY-AI: Artificial intelligence based precision oncology clinical trial matching and [...]
Chinese-Based MedCDx and US-Based Admera Health Enter into Strategic Partnership to Co-develop Companion Diagnostics
South Plainfield, NJ-February 26, 2019 – Today, MedCDx and Admera Health announced a non-exclusive collaborative agreement. Under the terms of the agreement, MedCDx (formerly Qiagen Suzhou Translational Medicine) and Admera Health will gain access to each other’s existing portfolios and co-develop new technologies, specifically companion diagnostics. MedCDx has an [...]
Admera Health Genetic Tests are Now In-Network with CareFirst BlueCross BlueShield, Maryland, Washington D.C, and Northern Virginia
SOUTH PLAINFIELD, NJ, December 11, 2018 - Admera Health (www.admerahealth.com), an advanced molecular diagnostics company, announced today that its genetic testing services are now available as in-network benefits under CareFirst Blue Cross Blue Shield. With over 3.2 million members, CareFirst offers the widest coverage and the largest network for [...]